TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11376270

Group type: EXPERIMENTAL
Intervention: Ultrasonographically and stereotactically guided fine-needle aspiration biopsy (FNAB)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Ultrasonographically guided FNAB
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Stereotactically guided FNAB
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Detection of masses with FNAB
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Detection of calcifications with FNAB
Number of subjects: 442

Group type: COMPARATOR
Intervention: Core-needle biopsy and needle-localized open surgical biopsy
Number of subjects: 442
Study: 10771928

Group type: EXPERIMENTAL
Intervention: PRP‐T vaccine in association with DPT vaccine at different sites
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: PRP‐T and DPT both vaccines at the same site mixed in the same syringe
Number of subjects: 110

Group type: COMPARATOR
Intervention: PRP‐T vaccine
Number of subjects: 110
Study: 8290663

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 56
Study: 2883715

Group type: EXPERIMENTAL
Intervention: terfenadine 60 mg twice daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: dexchlorpheniramine 6 mg twice daily
Number of subjects: 42
Study: 30897999

Group type: EXPERIMENTAL
Intervention: Darapladib
Number of subjects: 10634

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: Darapladib or Placebo
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: History of stroke
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: High-density lipoprotein cholesterol
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus requiring treatment
Number of subjects: 10634

Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 10634
Study: 27701683

Group type: EXPERIMENTAL
Intervention: Saffron (30 mg/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Citalopram (40 mg/day)
Number of subjects: 66
Study: 26809344

Group type: EXPERIMENTAL
Intervention: Usual care plus text-message reminder
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3200
Study: 23942244

Group type: EXPERIMENTAL
Intervention: Placebo-aerobic training (PLA-AT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Estrogen therapy-aerobic training (ET-AT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo-control
Number of subjects: 42

Group type: COMPARATOR
Intervention: Estrogen therapy-control
Number of subjects: 42
Study: 22769041

Group type: EXPERIMENTAL
Intervention: Augmented Cognitive Behavioural Therapy (CBT) intervention, which includes principles of recognizing, registering, and altering negative thoughts, augmented with direct in-vivo activation by occupational or movement therapists.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Computerized cognitive training intervention (Control group).
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Augmented CBT intervention.
Number of subjects: 106
Study: 19640972

Group type: EXPERIMENTAL
Intervention: High cruciferous vegetable diet (14 g cruciferous vegetables/(kg body weightd))
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-phytochemical, low-fiber basal diet
Number of subjects: 17
Study: 17466587

Group type: EXPERIMENTAL
Intervention: Pulsed high-frequency electromagnetic field (pulsed EMF) emitted by a mobile phone for thirty minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham exposure for thirty minutes
Number of subjects: 10
Study: 15955854

Group type: EXPERIMENTAL
Intervention: PTA and brachytherapy
Number of subjects: 199

Group type: COMPARATOR
Intervention: PTA alone
Number of subjects: 199
Study: 12670123

Group type: EXPERIMENTAL
Intervention: 100% oxygen at 2 atm abs (HBO2)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Increased atmospheric pressure (10.5% oxygen at 2 atm abs)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 5

Group type: COMPARATOR
Intervention: Hyperoxia (100% oxygen)
Number of subjects: 5
Study: 10379619

Group type: EXPERIMENTAL
Intervention: Zolpidem (5, 10, 20 mg/70 kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Triazolam (0.125, 0.25, 0.5 mg/70 kg)
Number of subjects: 18
Study: 8537264

Group type: EXPERIMENTAL
Intervention: Dirithromycin, 500 mg once daily for 5 days
Number of subjects: 191

Group type: COMPARATOR
Intervention: Clarithromycin, 250 mg twice daily for 7 days
Number of subjects: 191
Study: 1665118

Group type: EXPERIMENTAL
Intervention: Flunarizine (FLN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6119872

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31743793

Group type: EXPERIMENTAL
Intervention: Vegan diet emphasizing minimally-processed whole foods from plants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat omnivorous diet
Number of subjects: 0
Study: 30621476

Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional energy-restricted diet (C)
Number of subjects: 80
Study: 28818674

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) administered 24 hours prior to surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 40
Study: 26428278

Group type: EXPERIMENTAL
Intervention: Palm date consumption (seven dates, approximately 50 g)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (maltodextrin‐dextrose, 37·1 g)
Number of subjects: 22
Study: 23422397

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (40 IU 4 times per day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 21287538

Group type: EXPERIMENTAL
Intervention: Boswellia serrata (BS) 4200 mg/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 44
Study: 19594003

Group type: EXPERIMENTAL
Intervention: Minimally invasive THA (mini‐incision group)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional THA (conventional incision group)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 17190867

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy with Defibrillator (CRT-D)
Number of subjects: 217
Study: 15042528

Group type: EXPERIMENTAL
Intervention: Rituximab plus CHOP
Number of subjects: 399

Group type: COMPARATOR
Intervention: CHOP alone
Number of subjects: 399
Study: 10893915

Group type: EXPERIMENTAL
Intervention: Breastfeeding support including anticipatory counseling and monthly clinical follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no breastfeeding support)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention group (breastfeeding support)
Number of subjects: 0
Study: 9003086

Group type: EXPERIMENTAL
Intervention: DNA flow cytometry
Number of subjects: 30
Study: 1342280

Group type: EXPERIMENTAL
Intervention: Lifestyle interventions (weight loss, sodium restriction, stress management)
Number of subjects: 2182

Group type: EXPERIMENTAL
Intervention: Nutrition supplements (calcium, magnesium, potassium, fish oil)
Number of subjects: 2182

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2182
Study: 3158327

Group type: EXPERIMENTAL
Intervention: 1% zinc pyrithione shampoo
Number of subjects: 32

Group type: COMPARATOR
Intervention: Shampoo without zinc pyrithione (placebo)
Number of subjects: 32
Study: 3310910

Group type: EXPERIMENTAL
Intervention: Dermabrasion performed six to eight months after grafting
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control subjects (no dermabrasion)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Dermabrasion
Number of subjects: 192
Study: 31535213

Group type: EXPERIMENTAL
Intervention: 136.6 mg isoflavones (as aglycone equivalents)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 30466866

Group type: EXPERIMENTAL
Intervention: EPA (2 g per day)
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: Aspirin (300 mg per day)
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: EPA plus Aspirin
Number of subjects: 709

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 709
Study: 26830694

Group type: EXPERIMENTAL
Intervention: MCO (multi-criteria optimization)
Number of subjects: 10
Study: 25703878

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 837

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 837
Study: 24071754

Group type: EXPERIMENTAL
Intervention: CRAFT family education program (6 weekly 2 hour sessions)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Gam-Anon 12-step program
Number of subjects: 44
Study: 20160396

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Non-statin treatment
Number of subjects: 1016
Study: 17888410

Group type: EXPERIMENTAL
Intervention: 24 IU oxytocin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 16632782

Group type: EXPERIMENTAL
Intervention: Sonography with a 6.5-MHz micro convex probe
Number of subjects: 100
Study: 15156808

Group type: EXPERIMENTAL
Intervention: Thermal ablation with a bipolar multielectrode 3 mm Covac wand (power 3 setting)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Thermal ablation with a bipolar multielectrode 3 mm Covac wand (power setting 7)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resection with a motorized 4.5 full‐radius resector
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resection with a scalpel blade
Number of subjects: 16
Study: 10895748

Group type: EXPERIMENTAL
Intervention: i.m. ketamine 0.5-0.6 mg kg-1
Number of subjects: 80

Group type: COMPARATOR
Intervention: i.m. morphine 0.1-0.15 mg kg-1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 8884413

Group type: EXPERIMENTAL
Intervention: Sleep/wake cycles and meal-times advanced for two hours (Day 2)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sleep/wake cycles and meal-times delayed for two hours (Day 3)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control days (Days 1 and 4)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Only sleep/wake cycle advanced for two hours (Day 5)
Number of subjects: 8
Study: 1401691

Group type: EXPERIMENTAL
Intervention: Shoes with thick, soft midsoles
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Shoes with thick midsoles
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Barefoot
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Higher comfort shoe types
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Shoes with thin, hard soles
Number of subjects: 25
Study: 4076532

Group type: EXPERIMENTAL
Intervention: Cimetropii bromidum (10 or 20 mg i.v.)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 30635696

Group type: EXPERIMENTAL
Intervention: Abaloparatide
Number of subjects: 416

Group type: COMPARATOR
Intervention: Teriparatide
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 416
Study: 29664851

Group type: EXPERIMENTAL
Intervention: Self-directed home exercise
Number of subjects: 51

Group type: COMPARATOR
Intervention: Formal outpatient physical therapy (PT)
Number of subjects: 51
Study: 26946990

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise
Number of subjects: 92

Group type: COMPARATOR
Intervention: Light intensity exercise
Number of subjects: 92

Group type: COMPARATOR
Intervention: Reading control group
Number of subjects: 92
Study: 24213610

Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hypoxia (induced by lowering arterial saturation to 90% and 80%)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hypercapnia (increased end‐tidal CO2 10 mmHg above baseline)
Number of subjects: 28
Study: 23341531

Group type: EXPERIMENTAL
Intervention: SOC + TNFerade
Number of subjects: 304

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 304
Study: 20582493

Group type: EXPERIMENTAL
Intervention: T8 floating tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release tablets (Vastrel® 20 mg)
Number of subjects: 0
Study: 18837755

Group type: EXPERIMENTAL
Intervention: Bleaching protocol 1
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bleaching protocol 2
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no bleaching)
Number of subjects: 75
Study: 16822597

Group type: EXPERIMENTAL
Intervention: DTPa-IPV+MMR
Number of subjects: 362

Group type: COMPARATOR
Intervention: DTPa+IPV+MMR
Number of subjects: 362
Study: 14607350

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 10871715

Group type: EXPERIMENTAL
Intervention: Tamoxifen trial participants (n=53)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Women who declined the trial (n=53)
Number of subjects: 106
Study: 8959081

Group type: EXPERIMENTAL
Intervention: FSH (Metrodin, 150 units)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 21
Study: 1558571

Group type: EXPERIMENTAL
Intervention: Children with epilepsy
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Untreated patients (N = 13)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control children
Number of subjects: 112
Study: 3937005

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tocainide infusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral tocainide therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31562496

Group type: EXPERIMENTAL
Intervention: 3.0% NaCl (hypertonic)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% NaCl (isotonic)
Number of subjects: 60
Study: 30761795

Group type: EXPERIMENTAL
Intervention: Testosterone gel (Androgel) at a daily dose of 5 g (1 sachet)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Testosterone gel (Androgel) at a daily dose of 10 g (2 sachets)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Basic therapy (exercise, diet, multivitamins)
Number of subjects: 90
Study: 27571129

Group type: EXPERIMENTAL
Intervention: Liposomal cytarabine with systemic dexamethasone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triple intrathecal therapy (TIT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Liposomal cytarabine
Number of subjects: 40
Study: 24121146

Group type: EXPERIMENTAL
Intervention: rabeprazole 10 mg/day
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: rabeprazole 5 mg
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: rabeprazole 10 mg
Number of subjects: 268

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 268
Study: 22493910

Group type: EXPERIMENTAL
Intervention: Deep puncturing group (32 cases)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Shallow puncturing group (31 cases)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 63
Study: 20537753

Group type: EXPERIMENTAL
Intervention: 8-mm covered stent
Number of subjects: 45

Group type: COMPARATOR
Intervention: 10-mm covered stent
Number of subjects: 45
Study: 18501262

Group type: EXPERIMENTAL
Intervention: Brief interpersonal psychotherapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: 20 mg daily of the SSRI antidepressant paroxetine
Number of subjects: 257

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 257
Study: 15680142

Group type: EXPERIMENTAL
Intervention: High frequency words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low frequency words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High phonotactic frequency nonwords
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low phonotactic frequency nonwords
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monolingual group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilingual group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Language familiarity
Number of subjects: 0
Study: 12752560

Group type: EXPERIMENTAL
Intervention: Cycling until exhaustion on a bicycle ergometer
Number of subjects: 81
Study: 10475292

Group type: EXPERIMENTAL
Intervention: Neostigmine 2.5 mg i.v. and glycopyrrolate 0.5 mg i.v. for reversal of residual neuromuscular blockade
Number of subjects: 100

Group type: COMPARATOR
Intervention: No neostigmine administration
Number of subjects: 100
Study: 8542854

Group type: EXPERIMENTAL
Intervention: Bupivacaine plus buprenorphine (7.2 mg kg‐1 of buprenorphine with 1.8 mg kg‐1 of bupivacaine)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bupivacaine plus buprenorphine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bupivacaine alone (1.8 mg kg‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bupivacaine alone
Number of subjects: 30
Study: 2014357

Group type: EXPERIMENTAL
Intervention: Postural drainage (PD) and forced expiration technique (FET)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Postural drainage (PD) and forced expiration technique (FET) with fast percussion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Postural drainage (PD) and forced expiration technique (FET) with slow percussion
Number of subjects: 9
Study: 7026018

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (no levamisole)
Number of subjects: 55
Study: 31073880

Group type: EXPERIMENTAL
Intervention: Positive Search Training (PST)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioural Intervention (CBI)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Curriculum-as-Usual (CAU)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Depressive Symptoms
Number of subjects: 303
Study: 28481967

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab at randomization
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Chemotherapy followed by bevacizumab after disease progression (PD)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Chemotherapy alone (control group)
Number of subjects: 361
Study: 25721074

Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 37
Study: 22563991

Group type: EXPERIMENTAL
Intervention: Oral health promotion activities (intervention)
Number of subjects: 1675

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1675
Study: 21282542

Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg/d
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Erlotinib 150 mg/d
Number of subjects: 1240
Study: 19329464

Group type: EXPERIMENTAL
Intervention: Compomer restorations
Number of subjects: 534

Group type: COMPARATOR
Intervention: Amalgam restorations
Number of subjects: 534
Study: 16899475

Group type: EXPERIMENTAL
Intervention: oral oestradiol‐17beta 1 mg plus norethisterone acetate 0.5 mg daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: matching placebo
Number of subjects: 100
Study: 14976888

Group type: EXPERIMENTAL
Intervention: Combination therapy of clomiphene and Chinese drugs for nourishing Shen and activating blood circulation (NSABC)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Clomiphene alone (Control)
Number of subjects: 62
Study: 11182704

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9429989

Group type: EXPERIMENTAL
Intervention: apoE3/2 or apoE3/3
Number of subjects: 28

Group type: COMPARATOR
Intervention: apoE4/2, apoE4/3, or apoE4/4
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: apoE3/2 and apoE3/3
Number of subjects: 28
Study: 7636533

Group type: EXPERIMENTAL
Intervention: Acitretin 30 mg/d for 6 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 2693439

Group type: EXPERIMENTAL
Intervention: Dexamethasone (25 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (15 patients, not given dexamethasone)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dexamethasone vs No Dexamethasone
Number of subjects: 40
Study: 701217

Group type: EXPERIMENTAL
Intervention: System A - cash prize drawings of $20 for no absenteeism during a 3-week period
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: System B - cash prize drawings of $20 for not being absent on eight randomly selected dates from the 3-week period
Number of subjects: 92

Group type: COMPARATOR
Intervention: Both reward systems
Number of subjects: 92

Group type: COMPARATOR
Intervention: Income level
Number of subjects: 92
Study: 31350938

Group type: EXPERIMENTAL
Intervention: Hochu-ekki-to (HET) 7.5 g oral per day, n = 9
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group, n = 9
Number of subjects: 18
Study: 28379607

Group type: EXPERIMENTAL
Intervention: Autologous skin cell suspension plus hydrocolloid dressings
Number of subjects: 106

Group type: COMPARATOR
Intervention: Hydrocolloid dressings alone
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Autologous skin cell suspension
Number of subjects: 106
Study: 25928696

Group type: EXPERIMENTAL
Intervention: Mediterranean dietary pattern (MedDiet) for 6 months
Number of subjects: 166

Group type: COMPARATOR
Intervention: Customary lifestyle and diet (Control)
Number of subjects: 166
Study: 25110222

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (malabsorptive procedure)
Number of subjects: 20
Study: 21744377

Group type: EXPERIMENTAL
Intervention: Duloxetine (mean 78.7 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40